Ramsay Health Care Ltd (ASX: RHC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Ramsay Health Care Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Ramsay Health Care Ltd (ASX: RHC)
Latest News
Blue Chip Shares
2 top ASX blue-chip shares to buy according to experts
Broker Notes
Buy, hold, sell: Wildcat Resources, Ramsay Health Care, CBA shares
Healthcare Shares
Ramsay Health Care vs Sonic Healthcare: Which healthcare stock is better value?
Broker Notes
Buy, hold, sell: Woodside, Life360, Ramsay Health Care shares
Healthcare Shares
Expert names 'undervalued' ASX 200 healthcare stock to buy today
ASX Share Market News
5 things to watch on the ASX 200 on Thursday
Healthcare Shares
Telix Pharmaceuticals vs Ramsay Healthcare: Which ASX healthcare stock made investors richer in 2026?
ASX Share Market News
ASX 200 healthcare shares lead a weaker market amid 82% chance of a rate hike
Broker Notes
6 ASX 200 shares boosted by brokers this week
Healthcare Shares
CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded
ASX Share Market News
Santos, Ramsay Health Care, and AMP shares reach new 52-week highs: Can they keep climbing?
Investing Strategies
Worried about a downturn? 3 ASX shares and 3 ETFs built to weather it
Frequently Asked Questions
-
Yes, Ramsay Health Care has historically paid two fully franked dividends a year.
-
Ramsay Health Care generally pays its shareholder dividends in March and September.
-
Ramsay Health Care Ltd listed on the ASX on 24 September 1997.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 03 Sep 2026 | $0.4850 | 100.00% | Final | 24 Sep 2026 |
| 09 Mar 2026 | $0.4250 | 100.00% | Interim | 26 Mar 2026 |
| 03 Sep 2025 | $0.4000 | 100.00% | Final | 25 Sep 2025 |
| 06 Mar 2025 | $0.4000 | 100.00% | Interim | 27 Mar 2025 |
| 04 Sep 2024 | $0.4000 | 100.00% | Final | 26 Sep 2024 |
| 11 Mar 2024 | $0.4000 | 100.00% | Interim | 05 Apr 2024 |
| 06 Sep 2023 | $0.2500 | 100.00% | Final | 29 Sep 2023 |
| 06 Mar 2023 | $0.5000 | 100.00% | Interim | 30 Mar 2023 |
| 05 Sep 2022 | $0.4850 | 100.00% | Final | 29 Sep 2022 |
| 07 Mar 2022 | $0.4850 | 100.00% | Interim | 31 Mar 2022 |
| 06 Sep 2021 | $1.0300 | 100.00% | Final | 30 Sep 2021 |
| 08 Mar 2021 | $0.4850 | 100.00% | Interim | 31 Mar 2021 |
| 05 Mar 2020 | $0.6250 | 100.00% | Interim | 27 Mar 2020 |
| 05 Sep 2019 | $0.9150 | 100.00% | Final | 30 Sep 2019 |
| 06 Mar 2019 | $0.6000 | 100.00% | Interim | 29 Mar 2019 |
| 05 Sep 2018 | $0.8650 | 100.00% | Final | 28 Sep 2018 |
| 06 Mar 2018 | $0.5750 | 100.00% | Interim | 29 Mar 2018 |
| 05 Sep 2017 | $0.0000 | 100.00% | Final | 28 Sep 2017 |
| 07 Mar 2017 | $0.5300 | 100.00% | Interim | 29 Mar 2017 |
| 06 Sep 2016 | $0.7200 | 100.00% | Final | 29 Sep 2016 |
| 08 Mar 2016 | $0.4700 | 100.00% | Interim | 30 Mar 2016 |
| 08 Sep 2014 | $0.5100 | 100.00% | Final | 24 Sep 2014 |
| 04 Mar 2014 | $0.3400 | 100.00% | Interim | 26 Mar 2014 |
| 03 Sep 2013 | $0.4150 | 100.00% | Final | 25 Sep 2013 |
| 04 Mar 2013 | $0.2900 | 100.00% | Interim | 27 Mar 2013 |
| 05 Mar 2012 | $0.2550 | 100.00% | Interim | 28 Mar 2012 |
| 02 Sep 2011 | $0.2950 | 100.00% | Final | 26 Sep 2011 |
| 08 Mar 2011 | $0.2250 | 100.00% | Interim | 28 Mar 2011 |
| 31 Aug 2010 | $0.2500 | 100.00% | Final | 27 Sep 2010 |
| 16 Mar 2010 | $0.1850 | 100.00% | Interim | 09 Apr 2010 |
| 21 Sep 2009 | $0.2150 | 100.00% | Final | 09 Oct 2009 |
| 20 Mar 2009 | $0.1650 | 100.00% | Interim | 08 Apr 2009 |
| 25 Sep 2008 | $0.1750 | 100.00% | Final | 15 Oct 2008 |
| 26 Sep 2007 | $0.1600 | 100.00% | Final | 12 Oct 2007 |
| 27 Mar 2006 | $0.1050 | 100.00% | Interim | 12 Apr 2006 |
| 26 Sep 2005 | $0.1150 | 100.00% | Final | 14 Oct 2005 |
| 16 Apr 2004 | $0.0750 | 100.00% | Interim | 30 Apr 2004 |
RHC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Ramsay Health Care Ltd
Ramsay Health Care Ltd (ASX: RHC) is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia.
As well as private hospitals, Ramsay operates day surgeries, primary care clinics, diagnostic and imaging centres, mental health facilities, pharmacies, and an expanding range of in-home and community care services.
It is the largest private hospital group in Australia, France, and the Scandanavian countries. Its 52.5%-owned subsidiary Ramsay Sante oversees its European operations. Its UK business includes mental health facilities and a range of clinical specialties.
The vast majority of the company's revenue is generated from its Australian and European operations.
RHC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Oct 2026 | $54.86 | $0.81 | 1.50% | 485,105 | $54.46 | $55.28 | $54.40 |
| 12 Oct 2026 | $54.05 | $-0.59 | -1.08% | 559,199 | $54.64 | $54.67 | $53.86 |
| 09 Oct 2026 | $54.64 | $0.10 | 0.18% | 375,703 | $54.40 | $54.91 | $53.86 |
| 08 Oct 2026 | $54.54 | $-0.01 | -0.02% | 886,473 | $54.43 | $54.80 | $54.33 |
| 07 Oct 2026 | $54.55 | $-0.15 | -0.27% | 773,851 | $54.70 | $55.07 | $54.48 |
| 06 Oct 2026 | $54.70 | $0.39 | 0.72% | 525,396 | $54.72 | $54.87 | $54.24 |
| 05 Oct 2026 | $54.31 | $-0.11 | -0.20% | 253,332 | $54.83 | $54.98 | $54.12 |
| 02 Oct 2026 | $54.42 | $-0.06 | -0.11% | 389,710 | $54.61 | $55.00 | $53.79 |
| 01 Oct 2026 | $54.48 | $-1.20 | -2.16% | 516,311 | $55.57 | $55.61 | $54.48 |
| 30 Sep 2026 | $55.68 | $0.20 | 0.36% | 847,240 | $55.26 | $55.84 | $55.12 |
| 29 Sep 2026 | $55.48 | $-0.08 | -0.14% | 446,235 | $55.58 | $55.80 | $55.17 |
| 28 Sep 2026 | $55.56 | $0.25 | 0.45% | 608,196 | $55.22 | $55.57 | $54.98 |
| 25 Sep 2026 | $55.31 | $-0.32 | -0.58% | 447,737 | $55.59 | $55.69 | $55.20 |
| 24 Sep 2026 | $55.63 | $0.22 | 0.40% | 557,422 | $55.15 | $55.70 | $54.87 |
| 23 Sep 2026 | $55.41 | $-0.09 | -0.16% | 738,913 | $55.50 | $55.98 | $55.15 |
| 22 Sep 2026 | $55.50 | $-0.11 | -0.20% | 656,650 | $55.75 | $55.85 | $55.19 |
| 21 Sep 2026 | $55.61 | $0.22 | 0.40% | 639,378 | $55.00 | $55.71 | $54.95 |
| 18 Sep 2026 | $55.39 | $0.26 | 0.47% | 2,536,052 | $55.14 | $55.40 | $54.65 |
| 17 Sep 2026 | $55.13 | $0.28 | 0.51% | 1,558,960 | $55.98 | $55.98 | $54.70 |
| 16 Sep 2026 | $54.85 | $1.28 | 2.39% | 846,886 | $54.05 | $54.85 | $53.90 |
| 15 Sep 2026 | $53.57 | $0.65 | 1.23% | 606,592 | $53.32 | $53.61 | $52.68 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 28 Aug 2026 | Michael Siddle | Sell | 1,000,000 | $49,000,000 |
Off-market trade. As per announcement on 28/08/2026
|
| 26 Mar 2026 | Steven Sargent | Buy | 619 | $24,979 |
On-market trade.
|
| 25 Mar 2026 | Craig Drummond | Buy | 15,000 | $602,788 |
On-market trade. average price per ordinary share
|
| 24 Mar 2026 | Karen Penrose | Buy | 701 | $27,625 |
On-market trade.
|
| 15 Dec 2025 | Natalie Davis | Issued | 74,075 | $2,618,551 |
Issue of securities. 131,547 Performance Rights
|
| 26 Nov 2025 | Natalie Davis | Issued | 21,071 | $675,011 |
Director remuneration. VWAP
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David Ingle Thodey | Non-Executive DirectorNon-Executive Chairman | Nov 2017 |
Mr Thodey is a business leader focused on innovation, technology, digital transformation and corporate governance. He is also Chair of Xero Limited, Chancellor the University of Sydney, co Chair of the Great Barrier Reef Foundation, a non executive member of the Reserve Bank of Australia Governance Board and the Bank of America Australia Advisory Board. He has over 40 years experience in business leadership including as CEO of Telstra and CEO of IBM Australia & New Zealand. David is active in public policy, having previously led various independent reviews including the myGov User Audit (2023) and the NSWs Government Federal Financial Relations Review (2020). He was also Chair of CSIRO (2015 to 2021) and Deputy Chair of the National COVID 19 Coordination Commission Advisory Board (2020).
|
| Ms Catriona Alison Deans | Non-Executive Director | Nov 2018 |
Ms Deans has 25 years experience building technology enabled businesses involved in media, ecommerce, financial services and health, and across leadership roles as an executive, a director and in venture capital. She is also Chair of Cochlear Limited, Chair of Calix Limited and a Non Executive Director of Fitness Passport and The Observership Program. She is also a Venture Partner of Main Sequence Ventures. In her executive career, she was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas and most recently CEO of Netus Pty Ltd (a technology investment company acquired by Fairfax). She also spent seven years as a consultant with McKinsey & Company.
|
| Mr Michael Stanley Siddle | Non-Executive Director | May 1975 |
Mr Siddle was re elected as a Non Executive Director in November 2023. He was Chair of the Company from 2014 to 2023, having formerly been Deputy Chairman for 17 years and a founding Director. He has built up significant knowledge of the business and the private hospital industry after starting with the Company in 1968. He has extensive experience in the management of private hospitals and has been integrally involved in Ramsay Health Cares successful expansion through developments, mergers and acquisitions. During the past three years he has not served as a director of any listed companies other than Ramsay Health Care Limited.
|
| Mr Craig Milton Drummond | Non-Executive Director | Jul 2025 |
Mr Drummond was appointed as a non executive director on 1 July 2025, and brings extensive executive and board level experience across healthcare, financial services and other regulated industries. He is also Chair of Transurban Group, Chair of the Australian Foundation Investment Company Limited, Chair of the AFL Commission and Chair of The Ian Potter Foundation. He has previously served as President and Director of the Geelong Football Club Ltd, a Director of the Florey Institute of Neuroscience and Mental Health, and a Member of the Federal Governments Financial Regulator Assessment Authority. His executive career includes five years as CEO of Medibank Private Ltd (2016 to 2021). He was formerly Group Executive Finance and Strategy at National Australia Bank, and CEO and Country Head at Bank of America Merrill Lynch (Australia). Earlier in his career, Craig held senior positions at Goldman Sachs JBWere.
|
| Ms Helen Kurincic | Non-Executive Director | Mar 2024 |
Ms Kurincic is an experienced director and senior executive bringing over 30 years of operational, executive and board-level experience across healthcare, specialist medicine, radiology and financial services. She is also Chair of McMillan Shakespeare and a Non Executive Director of Artrya Limited, Carlton Football Club and Carlton Imaging Pty Ltd. She was previously Chair of Integral Diagnostics and a Non Executive Director of HBF Health, Estia Health, Sirtex Medical, AMP Capital Investors Domain Principal Group, Melbourne Health, Orygen Youth Mental Health Research Centre and DCA Group. Beginning her career as an intensive care nurse, she transitioned into community health and aged care leadership and had an accomplished executive career, including as Chief Operating Officer of Genesis Care, CEO of Heart Care Victoria and CEO of Benetas.
|
| Ms Karen Lee Collett Penrose | Non-Executive Director | Mar 2020 |
Ms Penrose has had an extensive executive career in leadership and CFO roles, mainly in financial services. She is well versed in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. She has been a full-time director since 2014 and is an experienced committee chair of audit and risk. In addition to being a Non Executive Director of Ramsay, she also serves as a RHC appointee to the Board of Ramsay Generale de Sante and member of their Audit Committee. She also serves on the Boards of Bank of Queensland, Charter Hall Group and Cochlear. She is a Director of Marshall Investments Pty Limited and, in a voluntary capacity, a Director on Golf Australias Risk and Audit Committee.
|
| Mr Steven Andrew Sargent | Non-Executive Director | Nov 2021 |
Mr Sargents executive career included 22 years at General Electric, where he gained extensive multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe and Asia Pacific. In addition to being a Non-Executive Director of Ramsay, he also serves as a Director of Ramsay Generale de Sante and is the Chair of infection prevention company Nanosonics Limited. His unlisted board activities include Chairman of The Origin Foundation Limited, Origin Energys philanthropic arm, and Non-Executive Director of The Great Barrier Reef Foundation.
|
| Mr Natalie Davis | Chief Executive OfficerManaging Director | Dec 2024 |
Ms Davis joined Ramsay in October 2024 and was appointed Group CEO and Managing Director on 2 December 2024. She is also the Chair of Ramsay Generale de Sante SA. She is an accomplished senior executive and leader with extensive experience driving large scale strategic transformation, customer focus and growth. Since joining Ramsay, she has led the refresh of the Ramsay 2030 strategy, driving innovation, sustainable growth, capital discipline and a culture of performance, while embedding our purpose of people caring for people. She joined Ramsay after a decade with the Woolworths Group, where she held several roles including as Managing Director of Woolworths Supermarkets, Chief Customer Transformation Officer and Managing Director Woolworths NZ. Prior to joining Woolworths, She was a partner at McKinsey & Co, working in the Australian/New Zealand and UK offices over 15 years, serving clients on growth strategy and customer led transformation across a number of service sectors.
|
| Ms Henrietta Rowe | Company SecretaryGroup General Counsel | Jun 2019 |
-
|
| Henrietta Rowe | Company SecretaryGroup General Counsel |
-
|
|
| Anthony Neilson | Group Executive Finance |
-
|
|
| Brindan Suresh | Group Executive Health and Strategy |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 49,284,709 | 21.35% |
| J P Morgan Nominees Australia Pty Limited | 46,099,473 | 19.97% |
| Netwealth Investments Limited <Wrap Services A/C> | 33,484,240 | 14.51% |
| Citicorp Nominees Pty Limited | 29,804,026 | 12.91% |
| BNP Paribas Noms Pty Ltd | 6,611,597 | 2.86% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 6,457,173 | 2.80% |
| Paul Ramsay Holdings Pty Limited | 4,983,546 | 2.16% |
| BNP Paribas Nominees Pty Ltd <HUB24 Custodial Serv Ltd> | 3,056,111 | 1.32% |
| Woolwich Investments Pty Ltd <The Siddle Family Trust> | 2,750,000 | 1.19% |
| Argo Investments Limited | 1,907,299 | 0.83% |
| HSBC Custody Nominees (Australia) Limited <NT Comnwlth Super Corp A/C> | 1,824,045 | 0.79% |
| BNP Paribas Noms Pty Ltd <Global Markets> | 1,702,244 | 0.74% |
| UBS Nominees Pty Ltd | 810,647 | 0.35% |
| Citicorp Nominees Pty Limited <143212 NMMT Ltd A/C> | 708,145 | 0.31% |
| Netwealth Investments Limited <Super Services A/C> | 625,587 | 0.27% |
| BNP Paribas Noms (NZ) Ltd | 613,361 | 0.27% |
| BKI Investment Company Limited | 575,000 | 0.25% |
| Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 532,599 | 0.23% |
| Pillar Custodial Services Pty Ltd | 418,613 | 0.18% |
| IOOF Investment Services Limited <IPS Superfund A/C> | 381,311 | 0.17% |